U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07905495) titled 'Early Outcome of Simultaneous Bilateral Total Knee Replacement With and Without Tourniquet'... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07902505) titled 'Comparison of Telerehabilitation and Usual Rehabilitation After Knee or Hip Surgery' on Oct... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903623) titled 'QLS4131 Plus Isatuximab in Newly Diagnosed Primary Plasma Cell Leukemia' on Oct. 23. Brief... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07904546) titled 'ADBest TREAT Registry' on Oct. 13. Brief Summary: Atopic dermatitis is a chronic inflammat... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07902726) titled 'Adding Acetazolamide on Top of SGLT2 Inhibition in Persons With Type 2 Diabetes' on Oct. 20... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07905001) titled 'A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer' on Oc... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07904507) titled 'A Comparison of Beta-blockers and Calcium Channel Blockers in Atrial Fibrillation' on Oct. ... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07902934) titled 'Safety of NRICM301 Added to Standard Care in Adults With Acute Ischemic Stroke' on Oct. 21.... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903584) titled 'Personalized Drug Treatment of Frail Patients: Integrated Care and Real-Time Home Monitorin... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903272) titled 'A Trial Comparing Ramantamig and Daratumumab (Ramantamig-D) Versus Daratumumab, Bortezomib,... Read More